Diabeta
Diabeta
Diabeta (pronounced: /daɪəˈbiːtə/), also known as glyburide in the United States, is an oral sulfonylurea medication used to treat type 2 diabetes. It is marketed under various trade names, including Micronase, Glynase, and DiaBeta.
Etymology
The term "Diabeta" is derived from the Greek words "dia" meaning through and "beta", referring to the beta cells in the pancreas that produce insulin. The name signifies the drug's function, which is to stimulate the beta cells to release more insulin.
Usage
Diabeta is used in the management of type 2 diabetes when diet and exercise alone does not result in adequate glycemic control. It works by stimulating the release of insulin from the beta cells of the pancreas, thereby lowering blood glucose levels.
Side Effects
Common side effects of Diabeta include hypoglycemia (low blood sugar), nausea, heartburn, and weight gain. Severe side effects may include allergic reactions, jaundice, and low blood sodium levels.
Related Terms
- Sulfonylurea: A class of oral hypoglycemic drugs that stimulate insulin release from the beta cells of the pancreas.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Hypoglycemia: A condition characterized by an abnormally low level of blood sugar (glucose), your body's main energy source.
External links
- Medical encyclopedia article on Diabeta
- Wikipedia's article - Diabeta
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski